News

YourChoice Therapeutics, a biotech company based in California, has reported promising safety data from an early-stage ...
Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...